Error Note: This Substack contains an error because the adverse event reports were worldwide but the reporting rate per million doses only used USA dosing. The correction is explained here.
Though I haven’t fully vetted the site yet, I found another site like openvaers and grabbed some of the information from it.
In a normal year under typical vaccines, you see about 41 total reports of anaphylaxis (severe allergic reaction), but even one typical day at the VAERS desk sees more reports coming down the pipeline than what is seen all year in typical years under typical vaccines:
[click image to enlarge]
When put into “reports of anaphylaxis per million doses”, then by April 2021, it was already known that COVID jabs were causing 137 times as much anaphylaxis per million doses as typical vaccines cause.
Straight from this site, check out the adverse events of special interest which had accrued even before the 20-week mark after the rollout:
[click image to enlarge]
Vaccines shouldn’t be allowed to remain on the market if they cause over 100 times as many serious adverse events (life-threatening or requiring hospitalization) as other vaccines do.
It’d be fine for, say, a cancer medicine to be over 100 times more dangerous than a cold medicine, because those are medicines in different classes and being taken for different reasons — but we shouldn’t have any “medicines” of the same class that are more than 100 times more dangerous than the other “medicines” are.
COVID “vaccines” apparently cause more than 100 times more anaphylaxis, when the reporting rates are normalized to reports-per-million-doses.
Error Note: This Substack contains an error because the adverse event reports were worldwide but the reporting rate per million doses only used USA dosing. The correction is explained here.
Reference
[other site I found to accompany the efforts at openvaers.com] — VAERS Analysis. https://vaersanalysis.info/2021/05/23/vaers-summary-for-covid-19-vaccines-through-4-30-2021/
[Average rate of anaphylaxis reports over 11 years of observation was 41 per year or 0.24 per million net doses distributed] — MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. https://www.cdc.gov/mmwr/preview/mmwrhtml/ss5201a1.htm
Error Note: This Substack contains an error because the adverse event reports were worldwide but the reporting rate per million doses only used USA dosing. A corrected version will be coming out.